• Analysis

Medicare, private insurance and administrative costs: A Democratic talking point

Democrats such as Sens. Jeff Merkley and Bernie Sanders says Medicare is more efficient than private plans. But not so fast.

  • Analysis

Speaker Ryan’s fuzzy math on the nation’s ‘terrible tax system’

Ryan cited three numbers to make his case for lower corporate taxes, but there's a problem with each figure he used.

  • Analysis

Did James Comey violate federal laws?

We dig into the White House's rationale for suggesting that the fired FBI director violated federal laws.

Highlights
  • Analysis

365 days of Trump claims

Every suspect claim made by President Trump during his first year in office, in one place

The Trump Promise Tracker

Donald Trump made 60 key promises during the 2016 campaign. We will track his progress during his presidency.

The 2016 Election Fact Checker

Every fact check of Donald Trump and Hillary Clinton in one place.

  • Analysis

As the death toll climbs in Sudan, officials shy away from the ‘cholera’ label

The U.S. Embassy says people are dying from cholera, but WHO, USAID and Sudan's leaders hide behind a more benign-sounding phrase.

  • Analysis

President Trump’s claim foreign leaders told him they’re unhappy with 7-9 percent GDP growth

Trump keeps referencing conversations with two world leaders, but there's only one who could possibly have bragging rights.

  • Analysis

The House Republicans’ claim they have ‘passed more bills’ than recent first-year presidencies

House Republicans say they have passed more bills than any recent Congress. But passing bills is not the same as bills signed into law.

  • Analysis

President Trump’s claim that a wall will ‘stop much of the drugs from pouring into this country’

Trump wants the wall to stop drugs from entering the United States, but the majority of drugs are smuggled through legal ports of entry.

  • Analysis

President Trump’s repeated claim of credit for Foxconn’s deal in Wisconsin

The president keeps touting a deal that is still not approved, inked with a company with a history of not delivering.

Load More